Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Registry-based Non-interventional Analysis of Advanced/Metastatic Renal Carcinoma Treatment Patterns and Outcomes in the Hospital District of Southwest Finland.

NCT05363072 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05363072
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05363072 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Registry-based Non-interventional Analysis of Advanced/Metastatic Renal Carcinoma Treatment Patterns and Outcomes in the Hospital District of Southwest Finland.
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 2, 2022
Completion date
June 8, 2022
Enrollment
1,112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of kidney, cancer of the kidney, kidney cancer, kidney neoplasms, renal cancer, renal cell cancer, renal cell carcinoma